[Cystinuria]

Nephrol Ther. 2021 Apr:17S:S100-S107. doi: 10.1016/j.nephro.2020.03.001.
[Article in French]

Abstract

Cystinuria is the most common monogenic nephrolithiasis disorder. Because of its poor solubility at a typical urine pH of less than 7, cystine excretion results in recurrent urinary cystine stone formation. A high prevalence of high blood pressure and of chronic kidney disease has been reported in these patients. Alkaline hyperdiuresis remains the cornerstone of the preventive medical treatment. To reach a urine pH between 7.5 and 8 and a urine specific gravity less than or equal to 1.005 should be the goal of medical treatment. D-penicillamine and tiopronin, two cysteine-binding thiol agents, should be considered as second line treatments with frequent adverse events that should be closely monitored.

Keywords: Alcalinisation; Alkalinization; Calculs rénaux; Cysteine-binding thiol agents; Cystinuria; Cystinurie; Dérivés sulfhydrylés; Renal calculi.

Publication types

  • Review

MeSH terms

  • Cystine
  • Cystinuria* / diagnosis
  • Cystinuria* / epidemiology
  • Cystinuria* / therapy
  • Humans
  • Kidney Calculi*
  • Penicillamine
  • Tiopronin

Substances

  • Cystine
  • Tiopronin
  • Penicillamine